Lijoy Varghese
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cardio-renal-metabolic modeling in Asia-Pacific: projections of clinical and economic burden and empagliflozin's impact on burden reduction.
Journal: Journal of medical economics
Published: December 02, 2025
Cost-effectiveness of add-on empagliflozin versus standard of care in management of CKD in Malaysia, Thailand and Vietnam - findings from a modelling study assessing an EMPA-KIDNEY eligible population, using CKD progression model.
Journal: Journal of medical economics
Published: June 25, 2024
Cost-Effectiveness of Empagliflozin on Top of Standard of Care for Heart Failure With Reduced Ejection Fraction in Singapore.
Journal: Value in health regional issues
Published: March 15, 2022
Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 24, 2020
Health professionals' views about who would benefit from using a closed-loop system: a qualitative study.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: January 23, 2020
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
Journal: Applied health economics and health policy
Published: June 29, 2019
Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia.
Journal: Value in health regional issues
Published: June 28, 2019
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.
Journal: Journal of market access & health policy
Published: June 27, 2019
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Journal: PharmacoEconomics
Published: September 26, 2018
Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old.
Journal: Human vaccines & immunotherapeutics
Published: August 22, 2018
Comment on: 'Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada', Wilson et al., 22 June 2018.
Journal: Infectious diseases and therapy
Published: August 21, 2018
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.
Journal: Applied health economics and health policy
Published: April 11, 2018
Last Updated: 09/26/2026